学术与非学术机构冠状动脉CT血管成像的质量与安全性:来自大型欧洲注册研究(ESCR MR/CT注册研究)的启示
该研究分析了2010年1月至2020年1月欧洲19国47家学术机构与165家非学术机构的64,317例稳定症状患者,比较冠状动脉CT血管成像的图像质量、辐射剂量、不良事件及下游检查。结果显示两类机构诊断图像质量均达98%、不良事件率均0.4%,非学术机构下游检查转诊更多。
要点
- 学术与非学术机构CCTA诊断图像质量均达98%,扫描相关不良事件率均为0.4%。
- 非学术机构虽技术较旧,仍维持低辐射剂量(中位数4.76 mSv),高剂量扫描(>7 mSv)随时间下降30%。
- 非学术机构转诊无创缺血检查(6.5% vs 4.2%)及侵入性冠状动脉造影/手术(8.5% vs 5.6%)均多于学术机构。
核心结论
- 非学术与学术机构在欧洲均能提供安全、高质量的CCTA,但非学术机构在相似人群和CAD患病率下倾向于转诊更多患者进行下游检查。
研究设计与样本
- 分析大型多中心注册研究(ESCR MR/CT注册研究),纳入2010年1月至2020年1月欧洲19国47家(22%)学术机构和165家(78%)非学术机构的64,317例接受CCTA的稳定症状患者。
诊断标准与关键数值
- 学术机构与非学术机构诊断图像质量均报告为98%。
- 扫描相关不良事件率两类机构均为0.4%。
- 非学术机构辐射剂量中位数4.76 mSv(范围2.46-6.85 mSv),高剂量扫描(>7 mSv)随时间下降30%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To compare the use of coronary computed tomography angiography (CCTA) between academic and non-academic sites across Europe over the last decade.
METHODS: We analyzed a large multicenter registry (ESCR MR/CT Registry) of stable symptomatic patients who received CCTA 01/2010-01/2020 at 47 (22%) academic and 165 (78%) non-academic sites across 19 European countries. We compared image quality, radiation dose, contrast-media-related adverse events, patient characteristics, CCTA findings, and downstream testing between academic and non-academic sites.
RESULTS: Among 64,317 included patients (41% female; 60 ± 13 years), academic sites accounted for most cases in 2010-2014 (52%), while non-academic sites dominated in 2015-2020 (71%). Despite less contemporary technology, non-academic sites maintained low radiation doses (4.76 [2.46-6.85] mSv) with a 30% decline of high-dose scans ( > 7 mSv) over time. Academic and non-academic sites both reported diagnostic image quality in 98% of cases and low rate of scan-related adverse events (0.4%). Academic and non-academic sites examined similar patient populations (41% females both; age: 61 ± 14 vs. 60 ± 12 years; pretest probability for obstructive CAD: low 21% vs. 23%, intermediate 73% vs. 72%, high 6% both, CAD prevalence on CCTA: 40% vs. 41%). Nevertheless, non-academic sites referred more patients to non-invasive ischemia testing (6.5% vs. 4.2%) and invasive coronary angiography/surgery (8.5% vs. 5.6%).
CONCLUSIONS: Non-academic and academic sites provide safe, high-quality CCTA across Europe, essential to successfully implement the recently updated guidelines for the diagnosis and management of chronic coronary syndromes. However, despite examining similar populations with comparable CAD prevalence, non-academic sites tend to refer more patients to downstream testing.
KEY POINTS: • Smaller non-academic providers increasingly use CCTA to rule out obstructive coronary artery disease. • Non-academic and academic sites provide comparably safe, high-quality CCTA across Europe. • Compared to academic sites, non-academic sites tend to refer more patients to downstream testing.
引用
- Foldyna, Uhlig, Gohmann, et al. Quality and safety of coronary computed tomography angiography at academic and non-academic sites: insights from a large European registry (ESCR MR/CT Registry). Eur Radiol. 2022. PMID: 35267087. doi:10.1007/s00330-022-08639-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。